OBJECTIVE ASSESSMENT - EXAM
NR566 / NR 566 Week 2 Quiz (Latest
2026/2027): Advanced Pharmacology for Care
of the Family - Chamberlain 2026/2027
25 100% 2026/2027
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
* Pharmacokinetics & Pharmacodynamics * Therapeutic Monitoring & Patient Education
* Drug Interactions & Adverse Effects
COVER PAGE - 1
, SECTION
2026/2027):
1 | Pharmacokinetics
Advanced Pharmacology
& Pharmacodynamics
for Care of the| Family
Q1-Q9 -| Chamberlain
NR566 / NR 566
2026/2027
Week 2 2026/2027
Quiz (Latest
Q1
Q2
Q3
Q4
Q5
Q6
Q7
Q8
Q9 Question 9
1 of 25
2
3
4
5
6
7
8
A 60-year-old
45-year-old female
62-year-old
28-year-old
55-year-old
38-year-old
70-year-old
48-year-old
35-year-old male with is prescribed
with
hypertension
type
heart
HIVatrial
epilepsy
rheumatoid
osteoporosis
is2failure
started
diabetes
fibrillation
oral
is is
switched
is
arthritis
on
prescribed
contraceptives
isprescribed
isritonavir-boosted
is
prescribed
started
started
isfrom
started
on
furosemide
lisinopril
on
carbamazepine
alendronate
metformin
containing
digoxin
on methotrexate
darunavir.
1040
0.25
mg
500
mg
ethinyl
70daily.
mg
to
mg
mg
daily.
His
levetiracetam
daily.
twice
weekly.
estradiol
After
15
other
HemgHer
daily.
2has
medications
weekly.
weeks
She
renal
and
decreased
He
because
reports
his
function
has
Sheblood
pressure
is
levonorgestrel.
normal
she
albumin
mistakenly
include
taking
decreased
plans
the
renal
atorvastatin
due
remains
to
medication
takes
become
to
function.
with
She
malnutrition.
15
158/96
a creatinine
reports
40
mgpregnant.
with
After
mg
daily
mmHg.
her
daily
taking
1The
for
week
clearance
morning
Her
for
5nurse
The
St.
days
he
hyperlipidemia.
provider
John's
provider
reports
practitioner
coffee
before
of 40explains
wort
and
diarrhea
mL/min.
decides
herfor
breakfast
monitors
pharmacist
After
mild
that
After
to
and
2increase
depression.
carbamazepine
weeks
abdominal
for
then
5 days
identifies
reduced
lying
hethe
she
reports
Two
dose
cramping.
down
reports
the
diuretic
induces
months
error.
to
severe
for20
nausea
aefficacy.
mg.
nap.
hepatic
later
muscle
The
and
shepain
patient
visual
discovers
enzymes.
and dark
disturbances.
asks
urine.
shewhy
is pregnant.
the dose was not increased sooner.
A. Alendronate
These
Furosemide
She requires
symptomsis
absorption
immediate
highly
indicate
protein-bound
is leucovorin
lactic
increased
acidosis
and
byrescue
food
hypoalbuminemia
requiring
and
because
caffeine,
immediate
daily
enhancing
increases
discontinuation
dosingfree
its
causes
therapeutic
drugsevere
concentration
effect
bone
A.causing
marrow
The
These
St. toxicity
suppression
Carbamazepine
Ritonavir
John's
provider
are
B. Alendronate is
expected
wort
Gastrointestinal a
waspotent
induces
mustis
side and
concerned
aearly
CYP3A4
CYP3A4
be effects mucositis
CYP3A4
side
taken on about
effects
inducer
inhibitor
are first-pass
and that
ancommon that
P-glycoprotein,
that
will
increases
empty stomachmetabolism
increases
resolve with
metabolism
increasing
with metforminatorvastatin
limiting
continued
with plain earlyof
metabolism
therapy
initiation efficacy
levels,
many
water only, causing
drugs
and often and
and the including
improve
patient
reducing
oral
rhabdomyolysis
B.must
with contraceptives
Methotrexate
Furosemide
gradual
remain
Lisinopril
Digoxin efficacy
toxicity
requires isof
titration
upright
is
hashighly and
oral
a wide
for
likely
time warfarin
contraceptives
protein-bound
therapeutic
30
to
dueminutes
reach index
toand
to reduced prevent
steady-stateand
severe
renaldaily
esophageal
hypoalbuminemia
dosing is
concentration
clearance safe
irritation
for short
increasing
before can
the reduce
dose periods delivery to
elimination
adjustment
B.the
Thekidney,
C.half-life
St.
Carbamazepine
Darunavir
John's
Taking
patient
error decreasing
induces
wort
alendronate
is
provider has inhibits
iswaiting
harmless
was awith
CYP2C9,
developed efficacy
CYP2D6
CYP2C19,
fora decreasing
because
food inhibitor
causing
sulfonamide
prevents that
methotrexate
CYP2D6 atorvastatin
oral
decreases
gastric
allergycontraceptive
efficacy
isirritation
genotyping renally metabolism
cross-reacting
cleared and
accumulation
buttoreduces
results and
guide causing
of
with tricyclic
she haswithdrawal
absorption
metformin
dosing and
antidepressants
toxicity
normal
by only myopathy
kidney
10%
D.function
C. Furosemide
She
Carbamazepine
The oral
Metformin
The timing
Lisinopril isofis
combination
is experiencing not
contraceptive
causing
exhibits protein-bound
inhibits
causes
an failure
allergic
administration
hypoglycemia
zero-order does and
P-glycoprotein,
additive
isreaction
due
not
kinetics albumin
hepatotoxicity
to
whichpoor
matter levels
increasing
and absorption
should
presents
requiringbecause doalendronate
presenting not
absorption
gradualdiscontinue
with from affect
as its
concurrent
of
myalgia pharmacokinetics
digoxin
digoxin
GI symptoms
titration has and
aimmediately
ironjaundice
longsupplementation
half-life
Hypoalbuminemia
She
D. HIV shouldwort
TheJohn's
St. receive
Carbamazepine
infection
symptoms is increases
itself afolic
displaces
indicate
causes acid
reversiblefurosemide
supplementation
therapeutic
oral failurehalf-life
statin-induced
contraceptives
non-competitive and
myopathy
requiring
from leading
continue
inhibitor
proteintodoubling
through
doseof prolonged
the weekly
binding
CYP1A2 sitesdiuresis
schedule
immune-mediated without
mechanisms
concern
Correct Answer: B
Correct Answer: A B
Correct Answer: A
Rationale:
Metformin
Alendronate
Lisinopril, like
Rationale: commonly
has
most very
ACEcauses
poor oral
dose-related
inhibitors,bioavailability
requiresGIapproximately
side
(lesseffects
than 1%) including
which is diarrhea
5 half-lives further and
reduced
to reach cramping,
by food,
steady-state. which
coffee,
typically
Assessing and
improve
calcium.
efficacy
Furosemide
Rationale:
Digoxin
St. with
Carbamazepine
Ritonavir
John'sisIt
beforemustgradual
aispotent
isprimarily
wort be
greater taken
titration,
steady-state
isisaapotent
renally
CYP3A4
potent on an
thaninducer
90% taking
leads empty
eliminated.
hepatic
inhibitor.with
stomach
ofenzyme
CYP3A4meals,
protein-bound,
to premature
Reduced
Atorvastatinwith
or
dose
inducer,
and switching
plain
primarily
creatinine water.
escalation.
P-glycoprotein,
isparticularly
metabolizedto extended-release
toclearanceRemaining
albumin.
First-pass
of In
which
by
CYP3A4,severe
decreases
CYP3A4. upright
metabolism formulation.
for 30
hypoalbuminemia,
increases
CYP2C9, minutes
andand
Co-administration
clearance
the and Lactic
CYP2D6
metabolism
CYP1A2. less
prolongs are
of This
acidosis
prevents
not relevant
drug
increases
Methotrexate
significantlyisesophageal
rare
is estradiol
half-life,
ethinyl bound
leading toisand
metabolismand
increases
aand presents
lisinopril,
tofolateirritation
availablewhich
accumulation
progestins,
of
statin with
for
antagonist
numerous and
levels, fatigue,
ulceration,
issecretion
renally
reducing
andwith
raising
drugs myalgias,
toxicity. arisk
known
aeliminated.
into the
contraceptive
narrow
including
theNausea and
renal serious
therapeutic
of
oral respiratory
Zero-order
tubule,
myopathy
andefficacy. adverse
contraceptives,
visual
index.
and
Thisdistress.
potentially
kinetics effect
is applies
disturbances
Daily Metformin
of
rhabdomyolysis.
warfarin,
insteadtobisphosphonates.
a reducing drugs
well-documented
(yellow-green
and
of does
diuretic
like
weekly
This
other is not
response.cause
phenytoin,are not
antiepileptics.
dosing
drug-herb
a
halos)
well-known
causes
hypoglycemia
ACE
However,
classicinhibitors.
interaction.
It
severe
drug
is not
interaction
signs
toxicity
primarily ofas
increased
Inhibition,monotherapy.
including
digoxinfree
requiring
an fraction
inhibitor,
absorption
toxicity.
bone
statin
and can
marrow
dose
Allergicalso
issues,
its effects increase
reduction
suppression,
reactions
and onprotein toxicity.
P-glycoprotein
or present
switching
mucositis, The
displacement
with
to areprimary
pravastatin,
rash
and not
do clinical
whichconcern
hepatotoxicity.
and the
notangioedema,
primary
explain isthis
concern.inthese
Leucovorin
notnot heart
interaction.
CYP3A4 failure
rescue is is
symptoms.
reduced efficacy.
indicated for significant overdose. Folic acid is used for routine prophylaxis, not overdose.
metabolized.
NR566 / NR 566 Week 2 Quiz (Latest 2026/2027): Advanced Pharmacology for Care of the Family - Chamberlain 2026/2027 -- 2026/2027 | Passing Score: 80% | Page 2 of 0